113 related articles for article (PubMed ID: 11101360)
21. Inhibition of lymphocyte-mediated cytolysis and cyclic AMP phosphodiesterase by erythro-9-(2-hydroxy-3-nonyl)adenine.
Duncan GS; Wolberg G; Schmitges CJ; Deeprose RD; Zimmerman TP
J Immunopharmacol; 1982; 4(1-2):79-100. PubMed ID: 6296234
[TBL] [Abstract][Full Text] [Related]
22. Effects of chirality in 9-(2-hydroxy-3-nonyl)adenine upon deoxyribonucleic acid synthesis in herpes simplex virus-infected cells.
North TW; O'Connor L; Abushanab E; Panzica RP
Biochem Pharmacol; 1983 Dec; 32(23):3541-6. PubMed ID: 6316987
[TBL] [Abstract][Full Text] [Related]
23. Effect of chirality in erythro-9-(2-hydroxy-3-nonyl) adenine (EHNA) on adenosine deaminase inhibition.
Bessodes M; Bastian G; Abushanab E; Panzica RP; Berman SF; Marcaccio EJ; Chen SF; Stoeckler JD; Parks RE
Biochem Pharmacol; 1982 Mar; 31(5):879-82. PubMed ID: 7082355
[No Abstract] [Full Text] [Related]
24. Conformational change of adenosine deaminase during ligand-exchange in a crystal.
Kinoshita T; Tada T; Nakanishi I
Biochem Biophys Res Commun; 2008 Aug; 373(1):53-7. PubMed ID: 18549808
[TBL] [Abstract][Full Text] [Related]
25. Erythro-9-(2-hydroxy-3-nonyl)adenine (EHNA) blocks differentiation and maintains the expression of pluripotency markers in human embryonic stem cells.
Burton P; Adams DR; Abraham A; Allcock RW; Jiang Z; McCahill A; Gilmour J; McAbney J; Kaupisch A; Kane NM; Baillie GS; Baker AH; Milligan G; Houslay MD; Mountford JC
Biochem J; 2010 Dec; 432(3):575-84. PubMed ID: 20923411
[TBL] [Abstract][Full Text] [Related]
26. Tryptophan environment in adenosine deaminase. I. Enzyme modification with N-bromosuccinimide in the presence of adenosine and EHNA analogues.
Mardanyan S; Sharoyan S; Antonyan A; Armenyan A; Cristalli G; Lupidi G
Biochim Biophys Acta; 2001 Mar; 1546(1):185-95. PubMed ID: 11257521
[TBL] [Abstract][Full Text] [Related]
27. Erythro-9-(2-hydroxy-3-nonyl)adenine as a specific inhibitor of herpes simplex virus replication in the presence and absence of adenosine analogues.
North TW; Cohen SS
Proc Natl Acad Sci U S A; 1978 Oct; 75(10):4684-8. PubMed ID: 216993
[TBL] [Abstract][Full Text] [Related]
28. Enhancement of the anti-HIV-1 activity of ddAdo by coformycin, EHNA and deaza-EHNA derivatives.
Marongiu ME; Pani A; Tinti E; Grifantini M; Franchetti P; Cristalli G; La Colla P
New Microbiol; 1995 Oct; 18(4):359-70. PubMed ID: 8590388
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of adenosine deaminase by erythro-9-(2-hydroxy-3-nonyl)adenine (EHNA) mimics the effect of inescapable shock on escape learning in rats.
Woodson JC; Minor TR; Job RF
Behav Neurosci; 1998 Apr; 112(2):399-409. PubMed ID: 9588486
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of human T-cell rosette formation by the adenosine deaminase inhibitor erythro-9-(2-hydroxy-3-nonyl) adenine hydrochloride (EHNA).
Lum CT; Schmidtke JR; Sutherland DE; Najarian JS
Clin Immunol Immunopathol; 1978 Jul; 10(3):258-61. PubMed ID: 307473
[No Abstract] [Full Text] [Related]
31. Interaction of adenosine deaminase with inhibitors. Chemical modification by diethyl pyrocarbonate.
Mardanyan SS; Sharoyan SG; Antonyan AA; Lupidi G; Cristalli G
Biochemistry (Mosc); 2002 Jul; 67(7):770-7. PubMed ID: 12139475
[TBL] [Abstract][Full Text] [Related]
32. Differential cardioprotection with selective inhibitors of adenosine metabolism and transport: role of purine release in ischemic and reperfusion injury.
Abd-Elfattah AS; Jessen ME; Lekven J; Wechsler AS
Mol Cell Biochem; 1998 Mar; 180(1-2):179-91. PubMed ID: 9546645
[TBL] [Abstract][Full Text] [Related]
33. Endogenous adenosine modulation of 22Na uptake by rat brain synaptosomes.
Ribeiro JA; Lobo MG; Sebastião AM
Neurochem Res; 2003 Oct; 28(10):1591-5. PubMed ID: 14570405
[TBL] [Abstract][Full Text] [Related]
34. Enhanced oral bioavailability of 2'- beta-fluoro-2',3'-dideoxyadenosine (F-ddA) through local inhibition of intestinal adenosine deaminase.
DeGraw RT; Anderson BD
Pharm Res; 2001 Sep; 18(9):1270-6. PubMed ID: 11683239
[TBL] [Abstract][Full Text] [Related]
35. Adenosine deaminase inhibition enhances the inotropic response mediated by A1 adenosine receptor in hyperthyroid guinea pig atrium.
Kemeny-Beke A; Jakab A; Zsuga J; Vecsernyes M; Karsai D; Pasztor F; Grenczer M; Szentmiklosi AJ; Berta A; Gesztelyi R
Pharmacol Res; 2007 Aug; 56(2):124-31. PubMed ID: 17574432
[TBL] [Abstract][Full Text] [Related]
36. Suppression of human lymphocyte DNA and protein synthesis in vitro by adenosine and eight modified adenine nucleosides in the presence or in the absence of adenosine deaminase inhibitors, 2'-deoxycoformycin (DCF) and erythro-9-(2-hydroxy-3-nonyl) adenine (EHNA).
Ratech H; Kuritsky L; Thorbecke GJ; Hirschhorn R
Cell Immunol; 1982 Apr; 68(2):244-51. PubMed ID: 6980056
[No Abstract] [Full Text] [Related]
37. Structure-based de novo design of non-nucleoside adenosine deaminase inhibitors.
Terasaka T; Nakanishi I; Nakamura K; Eikyu Y; Kinoshita T; Nishio N; Sato A; Kuno M; Seki N; Sakane K
Bioorg Med Chem Lett; 2003 Mar; 13(6):1115-8. PubMed ID: 12643924
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of the effects of erythro-9(2-hydroxy-3-nonyl) adenine (EHNA) on HIV-1 production in vitro.
Sei Y; Inoue M; Tsuboi I; Yokoyama MM; Arora PK
Biochem Biophys Res Commun; 1989 Oct; 164(1):345-50. PubMed ID: 2478129
[TBL] [Abstract][Full Text] [Related]
39. Inhibition studies on membrane adenosine deaminase from human placenta.
Lupidi G; Marmocchi F; Cristalli G
Biochem Mol Biol Int; 1998 Dec; 46(6):1071-80. PubMed ID: 9891839
[TBL] [Abstract][Full Text] [Related]
40. Cardioprotection with adenosine metabolism inhibitors in ischemic-reperfused mouse heart.
Peart J; Matherne GP; Cerniway RJ; Headrick JP
Cardiovasc Res; 2001 Oct; 52(1):120-9. PubMed ID: 11557240
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
